Zhi Ling Teo 30th Lorne Cancer Conference 2018

Abstracts this author is presenting:

• Combined treatment with CDK4/6 and PI3Kα inhibitors is immunogenic and effective against triple-negative breast cancer   — Session 2 - Flash Talks and Melanoma Genomics